Hong Kong stock unusual movement | Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) surged more than 14%, the company stated that OAB-14 is in the second phase of clinical pre-preparation.

According to the Securities Times app, Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) surged over 14%, with the stock rising 14.21% to 6.52 Hong Kong dollars as of the time of publication, with a turnover of 46.7 million Hong Kong dollars.